Introduction
Neonatal seizures are a very common symptom. They may be the first manifestation of many neurological and non-neurological (e.g. endocrinological) dysfunctions and they have been statistically correlated with mortality and morbidity in the form of following epilepsy, cerebral palsy, and developmental delay (1) . The outcome of infants with neonatal seizures is also not well established. Seizures in a newborn infant are often important because they can indicate a disturbance of central nervous system (2) . It is critical to recognize neonatal seizures, to determine their etiology, and to treat them for three major reasons. First, the seizures are usually related to significant illness, sometimes requiring specific therapy. Second, neonatal seizures may interfere with important supportive measures, such as alimentation and assisted respiration for other associated disorders frequently present in neonates. Third, experimental data give reason for concern that the seizures per se may be a cause of brain injury and mental retardation and/or cognitive delay (3) .
In this review, we summarised the main new pathophysiological and clinical aspects of neonatal seizures.
An integrate aspect of the pathophysiological mechanisms of neonatal seizures
Clinically, a seizure appears when there is an excessive synchronous electrical discharge, for example depolarization of neurons within the cortex of central nervous system. The fundamental mechanisms of neonatal seizures are generally unknown, but current data suggest that the excessive depolarization may result for at least these following reasons: disturbance in energy production can result in a failure of the sodium-potassium pump. Hypoxemia, ischemia, and hypoglycemia can cause an abrupt reduction in energy production. Excess of excitatory versus inhibitory neurotransmitter can result in an excessive rate of depolarization. In presence of hypoxemia, ischemia and hypoglycemia, the extracellular level of glutamate (a principal excitatory extracellular in cortex) can increase for excessive release and diminished reuptake: this situation can cause an excessive neuronal excitation.
A relative deficiency of inhibitory versus excitatory neurotransmitter can result in an excessive rate of depolarizzation. For example, the brain concentration of γ-aminobutyric acid (GABA) (4) an inhibitory neurotransmitter, is decreased when the activity of its synthetic enzyme, glutamic acid decarboxylase, is depressed (5).
Finally, calcium and magnesium interact with the neuronal membrane to cause an inhibition of sodium movement. Consequently, hypocalcemia and hypomagnesemia would be excepted to cause an increase in sodium influx and depolarization (3) . From the clinical point of view, the main situations that are recognized as causes of neonatal seizures are the followings: hypoxia-ischemia that represents 50% of cases of neonatal seizures (6) .
Most asphyxiated infants with seizures have a moderate degree of encephalopathy (7) with different types of seizures, usually with early onset (frequently in the first 24 hours). Myoclonic and tonic seizures can occur in the most severe form of hypoxic ischemic encephalopathy and can be difficult to control pharmacologically. Many forms of central nervous system infections are associated to seizures that may be the first presentation. The most commonly isolated pathogens are Group B Streptococcus, Escherichia coli, Listeria spp, Staphylococcus and Pseudomonas species. A recent study demostrated that viral infection can be involved in the genesis of neonatal seizures (26%) (8) (9) (10) .
Intracranial haemorrhage in term infants can be due to birth trauma and may cause seizures independently of associated asphyxial insult. In particular, in preterm infants severe intraventricular hemorrhage, with or without associated parenchymal venous infarction, can be followed within a few hours by generalized tonic seizures. It is important to remember that isolated germinal matrix hemorrhage is unlikely to produce seizures. Cerebral artery infarction could be suspected in infants with seizures, in whom Apgar score is normal and subsequent investigation failed to discover an infective or metabolic etiology (11, 12) .
Seizure types and syndromes in neonatal seizures can be viewed as nonspecific response of the immature central nervous system to diverse insults. . Neonatal seizures differ in clinical description from those in adults, and seizures in preterm infants differ from those in term infants. Cerebral cortical organization, synaptogenesis, and myelination of cortical efferent pathways are poorly developed in human neonates, leading to weakly propagated, fragmentary seizures whose electrical activity may not spread to surface EEG electrodes. The more advanced development within the limbic system with connections to mid-brain and brain stem may explain the higher frequency of mouthing, eye deviation, and apnea in neonates than seizures in adults. Thus, the clinical manifestations can be extremely inconspicuous in neonates (13) (14) (15) .
Clinical types
Classically, there are four recognisable clinical seizures types: subtle, clonic, tonic and myoclonic. These seizures type were classified according to Volpe (13) , based on the descriptions of the quality and distributions of seizure behaviors. Each can be focal, multifocal (involves more than one site, is asynchronous, and often migratory), and generalised (diffusely bilateral, synchronous, and non-migratory).
Subtle
This type of seizures is more common in premature than in full term infants. Manifestations of subtle seizures include oro-facial symptons such as eye deviation, eyelid blinking, sucking, chewing, and lip smacking. Limb movements described as swimming, boxing or cycling can also indicate subtle seizure activity. It can be difficult to distinguish subtle seizures from jittering, an extremely common normal phenomenon in newborns. Jittering does not involve the face. The dominant movement in jittering is tremor, the alternating movements are rhythmic, of equal rate and amplitude.
Clonic
Clonic seizures involve one limb or one side of the face or body jerking rhythmically at a slow frequency (approximately 1-4 times/s). Clonic seizures are often a clue to an underlying focal lesion such as a cortical infarction, but they can be due to a metabolic cause. It is important to differentiate clonic seizures in the newborn as focal or multifocal. Focal clonic seizures involve, face, upper and/or lower extremities on one side of the body, or axial structures on one side of the body. On the contrary, multifocal clonic seizures involve several body parts, often in a migrating fashion, although the migration does not often follow a Jasksonian manner.
Tonic
Sustained posturing of the limbs or trunk, or deviation of the head or eyes are the usual manifestation of this type of seizures. There are two categories of tonic seizures: focal and generalized. Focal tonic seizures consist of sustained posturing of a limb or asymmetric posturing of trunk and/or neck. This type of seizure is generally associated with clear EEG seizure discharges. Generalized tonic seizures are characterized most commonly by tonic extension of both upper and lower extremities but also by tonic flexion of upper extremities with extension of lower extremities.
Myoclonic
Myoclonic jerks tend to occur in the flexor muscle groups. In rare cases, generalised myoclonic 
Common epileptic syndromes
Four epilepsy syndromes occurring in the neonatal period have been delineated (16) (17) (18) .
Benign idiopathic neonatal convulsion (Fifth day fits)
These seizures occur between day 1 and 7 of life, mostly between day 4 and 6. The prevalence is 4% of neonatal seizures. These seizures are usually partial clonic with alternating sides. A typical interictal EEG pattern that appears in 60% of neonates with this condition is a discontinued theta rhythm. Outcome is good with no recurrence of seizures or cognitive deterioration.
Benign familial neonatal convulsion
These seizures are dominantly inherited. In most patients, they start on the second or third day of life, but also can begin during the third month. The seizures are usually clonic, and there are no specific EEG criteria. Outcome is favorable, with only 14% of these children continuing to have seizures at a later stage. Most kindreds showed linkage to chromosome 20q. While linkage to this chromosome could not be demonstrated in some families, one kindred did show linkage to chromosome 8q, thus demonstrating the genetic heterogeneity of the syndrome. Mutations in the voltage gated K(+)-channel gene KCNQ2 are known to cause benign familial neonatal convulsions. Most KCNQ2 mutation can be predicted to truncate the protein. Only few aminoacid exchanges have been found, and their localization was restricted to either the pore region of the fourth or sixth transmembran regions. Dedek et al. (19) identified the first KCNQ2 mutation located within transmembran region 5. The clinical history of the two affected family members is not compatible with typical benign familial neonatal convulsion. The poor outcome in the index patient raises the question if at least some KCNQ2 mutations might increase the risk to develop therapy-resistant epilepsy. Additional studies are needed to evaluate the possibility of a causal relationship between KCNQ2 mutations and severe early infantile epilepsy (19) .
Early infantile epileptic encephalopsthy with suppression bursts: Ohtahara syndrome
This syndrome has an onset within the first 3 months of life, mainly during the first month. It is characterized by frequent tonic spasms, sometimes in clusters. There are also less frequent partial seizures and rare myoclonic seizures; EEG evidence shows suppression-burst patterns both in awake and sleep states. The etiologies are heterogenous, but this syndrome is usually associated with structural brain anomaly. The prognosis is very poor, with either early death or marked psychomotor retardation and intractable seizures (20, 21) . It can evolve into West syndrome in some patients (22) .
Early myoclonic epileptic encephalopathy
The seizures nearly always start in the neonatal period but can appear as late as 3 months of age. The seizure types include fragmentary myoclonus, massive myoclonus, partial seizures, and tonic spasm. Prognosis is very poor, with either early death and/or severe psychomotor retardation (23) .
Open questions in neonatal seizures

How is it possible to recognise neonatal seizures?
Neonatal seizures differ in clinical description from those in adults, and seizures in preterm infants differ from those in term infants. Cerebral cortical organization, synaptogenesis, and myelination of cortical efferent pathways are poorly developed in human neonates, leading to weakly propagate, fragmentary seizures whose electrical activity may not spread to surface EEG electrodes. The more advanced development within the limbic system with connection to mid-brain and brain-stem may explain the higher frequency of mouthing, eye deviation, and apnea in neonates than seizures in adults. Thus, the clinical manifestations can be extremely inconspicuous in neonates (24) .
The EEG (Figures 1 and 2 ) can provide confirmation that the observed neurological phenomena are seizures. However, not all clinical seizures are detected by EEG, particularly certain subtle seizures, most generalized tonic seizures and focal and multifocal myoclonic seizures (25, 26) . Two explanations have been proposed. The first is that some seizures may originate at a subcortical level (myoclonic) and are not propagated to surface electrodes because of the immature synaptogenesis and cortical projections (27, 28) .
The other is that subtle and generalised tonic seizures are not, in fact, epileptic due to central nervous system hypersynchronous electrical New trends in neonatal seizures A Verrotti et al discharge-but are primitive brain stem and spinal motor patterns released from tonic inhibition normally exerted by the forebrain (29) . In a recent study, it has been demostrated that the type of ictal discharge is related to gestational age: there is a rich variety in the onset, morphology, and frequency of the ictal discharges in both preterm and full term infants and neonatal ictal patterns lack a close correlation with underlying pathology (30) .
Moreover, Domenech-Martinez et al. (30) demonstrated the necessity to confirm by means of EEG record the neonatal clinical seizures, before and after having established the anticonvulsant treatment. Finally, in the last years, a great interest has been developed for amplitude integrated EEG cerebral function monitor (CFM) that can be an important technique for the neonatal neurologists. In particular, amplitude integrate EEG CFM is a reliable tool for monitoring both background patterns (especially normal and severely abnormal) and ictal activity. However, it has been shown that approximately half of all neonatal seizures may be missed using CFM alone. Neonatal seizures need to be diagnosed, characterised, and quantified first using EEG; the CFM may then be useful for long term monitoring (31) (32) (33) .
2.When is there a clearly indication of treatment ?
Several issues remain with respect to the treatment of neonatal seizures (32) . Some researchers argue that neonates should be treated only when seizures are clinical and prolonged, whereas brief electrographic seizures do not necessarily require treatment. This practice is controversial because there is evidence that electroencephalographic seizures detrimentally affect the immature brain (33) (34) (35) (36) (37) .
The special problems of electroclinical dissociation and the short duration of neonatal seizures make it difficult to be sure when to start and stop anticonvulsant treatment. There are good theoretical reasons for suppressing seizure activity but no clinical evidence that the generally poor outcome can be improved with anticonvulsant treatment. Certainly, in a newborn who suffers from repeated seizures, there is a serious brain injury that includes disturbance in the cerebral blood flow, energy metabolism and homeostasis of excitotoxic aminoacids. In one case, we observed a status epilepticus also in extremely low birth weight infants (38) . Moreover, the question of whether to treat neonatal seizures hinges upon the etiology and type of seizure. Little controversy exists regarding the treatment of symptomatic seizures. This opinion has been recently confirmed by Richard et al. (39) who underlines that phenobarbitone remain the mainstay of treatment and is effective in about onethird of cases, indeed babies who respond tend have a smaller seizures burden and relatively normal background EEG (39) . The prognosis is better than in those who require second line-treatment (40, 41) . In the last years, some important studies (42, 43) have reported significant improvement of degree of seizures control in neonates, using new anticonvulsant drugs. Second-line anticonvulsant regimens vary widely but usually involve benzodiazepines (diazepam, clonazepam, lorazepam, midazolam), phenytoin or paraldehyde. More recently, it seems that lignocaine can have an important role for the treatment of neonatal seizures. Lignocaine has a narrow therapeutic range and it can induce seizures in high doses. The drug can accumulate and so cannot be infused over very prolonged periods. Although there are some encouraging results with lignocaine, midazolam and clonazepam in particular in neonates with status epilepticus, the long term outcome of these children is not significantly improved. 
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What is the prognosis of neonatal seizures?
Some investigators have attempted to identify the neonatal variables that best correlate with outcome, but few prognostic indicators have been identified. It is well recognized that neonatal seizures are associated with the development of adverse neurologic sequelae in 25% to 35% of survivors (2, 3, 44) . However, it is less certain whether the particular types of seizures in neonates exert a significant influence on their outcomes. Neonatal seizures are rarely idiopathic and commonly considered as nonspecific responses of the immature central nervous system to different insults (e.g. hypoxic-ischemic encephalopathy) (40) . Lombroso (44) followed 46 patients and suggested that semiology might have prognostic importance. He concluded that the less obvious the clinical manifestations, the worse the prognosis, and conversely, the more vigorous the clinical manifestations, the better the ultimate prognosis. He reasoned that patients with well-organized seizures have a relatively impact central nervous system, whereas subtle seizures are commonly encountered in newborn infants whose cerebral function have been significantly compromised before the onset of their seizures. Duration may also be a critical factor. A number of studies (28, (45) (46) (47) (48) cite a high correlation between prolonged seizures and poor neurologic outcome; the Collaborative Prenatal Project addressed the issue in its review in 181 survivors of neonatal seizures: tonic and myoclonic seizures were the only types related to outcome. The former occurred significantly more often in children who had cerebral palsy (47), mental retardation, and epilpesy, whereas myoclonic seizures were correlated only with mental retardation. The authors did not speculate on the basis of these associations. A more recent multivariate analysis of 131 patients with neonatal seizures indicate that only tonic seizures were associated with adverse outcome (46) . The author cited the high occurrence of structural brain disease with this seizure type as the real cause. More recently, a study performed in 77 patients with seizures admitted to the neonatal intensive care unit over 7-year period, showed the following results: twenty-three (30%) died; 59% of the survivors had abnormal neurologic examinations, 40% were mentally retarded, 43% had cerebral palsy, and 21% were epileptic at mean follow-up of 3.5 years. Compared with patient with other seizure types, those with subtle and generalized tonic seizures had a significantly higher complication of epilepsy (P = 0.04 and P = 0.01 respectively); mental retardation (P = 0.02; P = 0.07) and cerebral palsy (P = 0.03; P = 0.002). In addition subtle seizures were more likely to be associated with abnormalities on the neurologic examination at follow-up (P = 0.03).
All this data seem to suggest that clinical semiology is predictive of outcome in neonates with seizures and suggest the presence of unique pathophysiologic processes for different seizure types. But it is important to remember that the etiology of seizures may be the most important factor in determining outcome. Poor prognosis has been noted in patients with malformations and hypoxic-ischemic insults, while primary subarachnoid hemorrhage and isolated hypocalcemia are associated with a favorable outcome. In a long term perspective, children who suffered from neonatal seizures but who subsequently were considered to have a normal outcome were followed up in their late teenage years: then showed difficulties with spelling, arithmetic and memory, despite having normal overall intelligence. This fact suggests that the underlying central nervous system vulnerability, which contributes to neonatal seizures, is associated with longer term clinical importance.
Conclusion
Neonatal seizures are rarely idiopathic and are commonly considered as non-specific responses of the immature central nervous system to different insults, including hypoxic-ischemic encephalopathy, severe intraventricular hemorrhage, cerebral infarction, metabolic disturbance, intracranial infection, and cerebral dysgenesia. Post-neonatal seizures and abnormal interictal EEG are the most important predictors of adverse outcome. Advances in neuroimaging, electroencephalography, biochemistry, and neuropharmacology have considerably improved our ability to evaluate and treat children with neonatal seizures. However, a prompt diagnosis, investigation, and treatment likely play the most relevant role on the child's subsequent neurological outcome.
